Theratechnologies to Present at the B. Riley Securities Virtual Oncology Investor Conference
January 14 2021 - 09:49AM
Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ:
THTX), a biopharmaceutical company focused on the development and
commercialization of innovative therapies, today announced that
Paul Levesque, President and Chief Executive Officer and Dr.
Christian Marsolais, Senior Vice President and Chief Medical
Officer will present at the B. Riley Virtual Oncology Investor
Conference on Wednesday, January 20, 2021 at 3:30 p.m. ET.
To access the live virtual presentation, please
visit the ‘News’ section of the Company’s website. A webcast replay
will also be available approximately two hours after the
presentation.
About Theratechnologies
Theratechnologies (TSX: TH) (NASDAQ: THTX) is a biopharmaceutical
company focused on the development and commercialization of
innovative therapies addressing unmet medical needs. Further
information about Theratechnologies is available on the Company's
website at www.theratech.com, on SEDAR at www.sedar.com and on
EDGAR at www.sec.gov.
For media inquiries:Denis BoucherVice-President, Communications
and Corporate Affairs514-336-7800
For investor inquiries:Leah GibsonSenior Director, Investor
Relationslgibson@theratech.com617-356-1009
Theratechnologies (NASDAQ:THTX)
Historical Stock Chart
From Feb 2024 to Mar 2024
Theratechnologies (NASDAQ:THTX)
Historical Stock Chart
From Mar 2023 to Mar 2024